ZAS Corporation Celebrates 19th Anniversary with Team Participation
ZAS Corporation proudly marked its 19th anniversary, celebrating nearly two decades of excellence, innovation, and growth. The milestone event saw […]
ZAS Corporation proudly marked its 19th anniversary, celebrating nearly two decades of excellence, innovation, and growth. The milestone event saw […]
We are thrilled to have welcomed our partners from the Morinaga Research Centre, Japan, to Bangladesh. This visit signifies a
ZAS Gyno, a division of ZAS Corporation Ltd., recently held an empowering sales conference titled “Sales Summit – Recharge &
We are delighted to announce that ZAS Corporation has successfully obtained the trademark for our brand Protimeal. Registered under trademark
We are proud to announce that ZAS Corporation Ltd. has officially secured the trademark for our brand DECA. Registered under
We are proud to announce the successful launch of Celltrion’s biosimilar products in Bangladesh, marking a significant milestone in our
Dhaka, Bangladesh – ZAS Corporation Ltd., a leading pharmaceutical company with a strong focus on oncology, recently held a transformative
ZAS Corporation, in collaboration with the Bangladesh Society of Critical Care Medicine (BSCCM), recently organized a scientific seminar focused on
ZAS Corporation is proud to announce the successful launch of Polymyxin B, a groundbreaking antibiotic from our Critical Care division.
ZAS Corporation Ltd. has pledged its support to the 4th International Scientific Conference of Bangladesh Perinatal Society, reinforcing its dedication